Venous thromboembolism (VTE) is a potentially life-threatening condition that can be
associated with significant morbidity. Thrombosis and cancer are linked by numerous …

The association between cancer and thrombosis has been recognized for more than 150
years. Not only are patients with cancer at a substantially increased risk of developing …

Cancer is a frequent finding in patients with thrombosis, and thrombosis is much more
prevalent in patients with cancer, with important clinical consequences. Thrombosis is the …

Cancer‐associated venous thromboembolism (VTE) is a leading cause of morbidity and
mortality in patients with cancer. Treatment of cancer‐associated VTE comes with a …

A broad range of studies suggest a two-way relationship between cancer and venous
thromboembolism (VTE). Patients with cancer have consistently been shown to be at …

Cancer and its treatments are well-recognized risk factors for venous thromboembolism
(VTE). Although the incidence of VTE in cancer patients is not well documented, there is …

Venous thromboembolism (VTE) represents a major challenge in the management of
patients with cancer. The malignant phenotype is associated with derangements in the …

Venous thromboembolism (VTE) is a common complication in patients with cancer. The risk
of emergent VTE is four-to seven-fold higher in cancer patients compared to non-cancer …

Venous thromboembolism (VTE) is a highly prevalent complication of malignancy with
emerging changes in incidence, diagnosis and treatment paradigms. This manuscript …

Venous thromboembolism (VTE) is a common complication in patients with cancer and
portends a poor prognosis. Our understanding of the underlying pathophysiology of VTE in …